Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer
- 27 March 2021
- journal article
- research article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 21 (4), 309-316
- https://doi.org/10.1016/j.clbc.2021.03.010
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Predicting Survival of De Novo Metastatic Breast Cancer in Asian Women: Systematic Review and Validation StudyPLOS ONE, 2014
- False-Positive [18F]Fluorodeoxyglucose-Avid Lymph Nodes on Positron Emission Tomography–Computed Tomography After Allogeneic but Not Autologous Stem-Cell Transplantation in Patients With LymphomaJournal of Clinical Oncology, 2014
- Comparison between whole-body MRI and Fluorine-18-Fluorodeoxyglucose PET or PET/CT in oncology: a systematic reviewRadiology and Oncology, 2013
- Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2013
- PET/CT and breast cancer subtypesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2013
- Pleural effusion: diagnosis, treatment, and managementOpen Access Emergency Medicine, 2012
- Focal fluorine-18 fluorodeoxyglucose-avid lesions without computed tomography correlate at whole-body positron emission tomography–computed tomography in oncology patientsNuclear Medicine Communications, 2011
- Initial Staging Impact of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Locally Advanced Breast CancerThe Oncologist, 2011
- Bone Imaging in Metastatic Breast CancerJournal of Clinical Oncology, 2004
- 18F-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography in Staging of Locally Advanced Breast CancerJournal of Clinical Oncology, 2004